Model | Range | Coefficient | OR (95% CI) | P |
---|---|---|---|---|

Biomarker alone | ||||

Intercept | NA | 0.07 | NA | 0.776 |

Biomarker | −18.88 to 16.91 | 0.13 | 1.14 (1.06-1.21) | 0.00017 |

Clinical variables alone | ||||

Intercept | NA | −5.01 | NA | 0.003 |

Age | 23-79 | 0.07 | 1.07 (1.02-1.13) | 0.008 |

Mass size | 0-1 | 2.19 | 8.91 (2.08-38.25) | 0.003 |

Lymphadenopathy | 0-1 | 2.09 | 8.12 (1.45-45.63) | 0.017 |

Biomarker + clinical variables | ||||

Intercept | NA | −4.9 | NA | 0.014 |

Biomarker | −18.88 to 16.91 | 0.13 | 1.13 (1.04-1.24) | 0.005 |

Age | 23-79 | 0.07 | 1.07 (1.00-1.14) | 0.036 |

Mass size | 0-1 | 1.85 | 6.38 (1.39-29.34) | 0.017 |

Lymphadenopathy | 0-1 | 2.75 | 15.69 (2.23-110.28) | 0.006 |

NOTE: The range, regression coefficients, odds ratio (OR), 95% confidence interval for the odds ratio (95% CI), and the *P* value of the variables across the training set samples (*n* = 76) are reported.